NRX Pharmaceuticals Inc

Research NRX Pharmaceuticals Inc (NRXP) on Bullrun: market cap USD 144.92M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNRXP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 144.92M
• Financial periodFY2025
• RevenueUSD 1.23M
• Net income-USD 28.62M
• Gross margin58.8%

Valuation Snapshot

latest market cap is USD 144.92M.

About NRX Pharmaceuticals Inc

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior;

Frequently asked questions

What is NRX Pharmaceuticals Inc's market cap?

NRX Pharmaceuticals Inc's market capitalization is USD 144.92M.

What does NRX Pharmaceuticals Inc do?

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.